Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 546,549 |
|
|||||
| News | - | ||||||
| Day High | 1.95 | Low High |
|||||
| Day Low | 1.60 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NKGen Biotech Inc | NKGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.35 | -17.68% | 1.63 | 19:42:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.90 | 1.60 | 1.95 | 1.61 | 1.98 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,089 | 546,549 | $ 1.76 | $ 960,030 | - | 0.7802 - 6.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:08 | formt | 500 | $ 1.63 | USD |
NKGen Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 35.24M | 21.89M | - | 0 | 4.55M | 0.21 | 7.75 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NKGen Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NKGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.8342 | 2.11 | 0.8342 | 1.56 | 8,722,050 | 0.7958 | 95.40% |
| 1 Month | 1.92 | 2.11 | 0.821 | 1.55 | 2,447,168 | -0.29 | -15.10% |
| 3 Months | 1.80 | 4.06 | 0.7802 | 1.86 | 3,800,099 | -0.17 | -9.44% |
| 6 Months | 3.66 | 5.10 | 0.7802 | 1.93 | 1,852,566 | -2.03 | -55.46% |
| 1 Year | 5.98 | 6.70 | 0.7802 | 1.94 | 1,632,252 | -4.35 | -72.74% |
| 3 Years | 5.98 | 6.70 | 0.7802 | 1.94 | 1,632,252 | -4.35 | -72.74% |
| 5 Years | 5.98 | 6.70 | 0.7802 | 1.94 | 1,632,252 | -4.35 | -72.74% |
NKGen Biotech Description
| NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform. Spearheading our industry disrupting technology are our Senior Leadership, Senior Advisors and Management Team. Together they bring a wealth of knowledge and expertise in neurodegeneration and immune-oncology and are passionate and excited about the work we are doing to strengthen the immune system. |
